Understand Why Semglee Will Be “Interchangeable” With Lantus

Semglee (insulin glargine-yfgn U-100) will be the first “interchangeable” biosimilar.

It was originally approved as a new brand of insulin glargine, not a Lantus generic...and switching required a new Rx. Now that’s changing.

Be aware of what an “interchangeable” biosimilar is.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote